Jeffrey Bluestone serves as Executive at Provention Bio, Inc., where they oversee executive responsibilities. Since joining the company, Jeffrey Bluestone has executed 9 insider transactions totaling $1.3M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 28, 2025 involved exercising options for 5,000 shares valued at $324.6K.
Jeffrey Bluestone currently holds 13,920 shares of Provention Bio, Inc. (PRVB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey Bluestone has been a net seller of PRVB stock. They have purchased $0 and sold $1.3M worth of shares.
Jeffrey Bluestone's most recent insider trade was on Nov 28, 2025, when they sold 5,000 shares at $64.92 per share.
Get notified when new Form 4 filings are submitted
| $125.08 |
| Discretionary |
| Jul 14, 2025 | GILD | $548.7K | Sale | 5,000 | $109.74 | Discretionary |
| Jul 14, 2025 | GILD | $337.3K | Option Exercise | 5,000 | $67.45 | Discretionary |
| May 5, 2022 | GILD | $0 | Award | 2,444 | $N/A | Discretionary |
| May 3, 2022 | GILD | $0 | Option Exercise | 2,223 | $N/A | Discretionary |
| Dec 8, 2021 | GILD | $0 | Option Exercise | 1,041 | $N/A | Discretionary |
| Apr 10, 2020 | PRVB | $76.1K | Option Exercise | 32,246 | $2.36 | Discretionary |
| Jun 17, 2019 | PRVB | $87.1K | Sale | 7,300 | $11.93 | Discretionary |